BioMed Research International / 2016 / Article / Tab 2

Research Article

Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea

Table 2

Clinical and biochemical characteristics of OSA patients.

MeasurementMild OSA ()Moderate OSA ()Severe OSA () value

Age (years)55.3 ± 9.352.5 ± 8.356.5 ± 7.5>0.05
Women/men6/128/168/12>0.05
BMI (kg/m2)26.2 ± 2.227.2 ± 2.729.3 ± 4.6<0.05
Waist circumference (cm)90.0 ± 3.990.9 ± 3.990.9 ± 4.3>0.05
TC (mmol/L)4.46 ± 0.604.91 ± 0.65.35 ± 0.67<0.05
LDL-C (mmol/L)2.98 ± 0.413.27 ± 0.373.36 ± 0.25<0.05
HDL-C (mmol/L)1.17 ± 0.101.15 ± 0.171.04 ± 0.24<0.05
TGs (mmol/L)2.15 ± 0.242.22 ± 0.302.15 ± 0.29>0.05
AHI (events/h)11.5 ± 2.420.8 ± 3.746.7 ± 13.8<0.01
Mean oxygen saturation (%)92.4 ± 1.589.9 ± 2.687.5 ± 3.4<0.01
Lowest oxygen saturation (%)80.2 ± 5.675.7 ± 5.065.4 ± 6.9<0.01
Oxygen saturation < 90% (%)20.9 ± 3.922.8 ± 3.926.0 ± 4.9<0.01
Fasting glucose (mmol/L)5.36 ± 0.795.57 ± 0.995.84 ± 0.99>0.05
Fasting insulin (mlU/L)17.7 ± 4.522.9 ± 8.427.2 ± 6.9<0.01
HOMA-IR2.34 ± 0.592.94 ± 0.993.46 ± 0.77<0.01
AEA (nmol/L) 2.65 ± 0.493.18 ± 0.623.61 ± 0.77<0.01
1/2-AG (nmol/L)38.8 ± 5.340.4 ± 4.940.9 ± 6.3>0.05

Data are presented as mean ± SD. Differences were considered significant when .